Reports

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

This kind of news seems to come up with some regular frequency - "To screen or not to screen, that is the question". This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower...

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was...

A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study "deeply flawed" and suggest...

Every once in a while there is a headline I just shake my head at, thinking, "how did this research get funded?" This is certainly not the most startling example of this but nonetheless I think most physicians already know this could reject a...

I haven't written much about the President's Cancer Moonshot initiative recently and as much as I would like - perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in...